285 related articles for article (PubMed ID: 30689633)
1. TLR4-interacting SPA4 peptide improves host defense and alleviates tissue injury in a mouse model of Pseudomonas aeruginosa lung infection.
Awasthi S; Singh B; Ramani V; Xie J; Kosanke S
PLoS One; 2019; 14(1):e0210979. PubMed ID: 30689633
[TBL] [Abstract][Full Text] [Related]
2. A TLR4-interacting SPA4 peptide inhibits LPS-induced lung inflammation.
Ramani V; Madhusoodhanan R; Kosanke S; Awasthi S
Innate Immun; 2013 Dec; 19(6):596-610. PubMed ID: 23475791
[TBL] [Abstract][Full Text] [Related]
3. Involvement of endoplasmic reticulum and histone proteins in immunomodulation by TLR4-interacting SPA4 peptide against
Awasthi S; Singh B; Ramani V; Godbole NM; King C
Infect Immun; 2023 Dec; 91(12):e0031123. PubMed ID: 37909750
[TBL] [Abstract][Full Text] [Related]
4. Lung and general health effects of Toll-like receptor-4 (TLR4)-interacting SPA4 peptide.
Awasthi S; Rahman N; Rui B; Kumar G; Awasthi V; Breshears M; Kosanke S
BMC Pulm Med; 2020 Jun; 20(1):179. PubMed ID: 32576172
[TBL] [Abstract][Full Text] [Related]
5. A toll-like receptor-4-interacting surfactant protein-A-derived peptide suppresses tumor necrosis factor-α release from mouse JAWS II dendritic cells.
Awasthi S; Brown K; King C; Awasthi V; Bondugula R
J Pharmacol Exp Ther; 2011 Mar; 336(3):672-81. PubMed ID: 21159752
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of Anti-Inflammatory Activity of TLR4-Interacting SPA4 Peptide.
Awasthi S; Kumar G; Ramani V; Awasthi V; Rodgers KK; Xie J; Beierle J; Kyere-Davies G; Singh B; Rahman N; Chowdhury AA; Chataut N
Immunohorizons; 2021 Aug; 5(8):659-674. PubMed ID: 34429343
[TBL] [Abstract][Full Text] [Related]
7. Surfactant proteins A and D enhance pulmonary clearance of Pseudomonas aeruginosa.
Giannoni E; Sawa T; Allen L; Wiener-Kronish J; Hawgood S
Am J Respir Cell Mol Biol; 2006 Jun; 34(6):704-10. PubMed ID: 16456184
[TBL] [Abstract][Full Text] [Related]
8. Redundant Toll-like receptor signaling in the pulmonary host response to Pseudomonas aeruginosa.
Skerrett SJ; Wilson CB; Liggitt HD; Hajjar AM
Am J Physiol Lung Cell Mol Physiol; 2007 Jan; 292(1):L312-22. PubMed ID: 16936244
[TBL] [Abstract][Full Text] [Related]
9. Acute exposure to silica nanoparticles enhances mortality and increases lung permeability in a mouse model of Pseudomonas aeruginosa pneumonia.
Delaval M; Boland S; Solhonne B; Nicola MA; Mornet S; Baeza-Squiban A; Sallenave JM; Garcia-Verdugo I
Part Fibre Toxicol; 2015 Jan; 12(1):1. PubMed ID: 25605549
[TBL] [Abstract][Full Text] [Related]
10. Effects of Pseudomonas aeruginosa and Streptococcus mitis mixed infection on TLR4-mediated immune response in acute pneumonia mouse model.
Song C; Li H; Zhang Y; Yu J
BMC Microbiol; 2017 Apr; 17(1):82. PubMed ID: 28376744
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas Aeruginosa pneumonia in cystic fibrosis.
Entezari M; Weiss DJ; Sitapara R; Whittaker L; Wargo MJ; Li J; Wang H; Yang H; Sharma L; Phan BD; Javdan M; Chavan SS; Miller EJ; Tracey KJ; Mantell LL
Mol Med; 2012 May; 18(1):477-85. PubMed ID: 22314397
[TBL] [Abstract][Full Text] [Related]
12. Effects of SPA4 peptide on lipopolysaccharide-disrupted lung epithelial barrier, injury, and function in a human cell system and mouse model of lung injury.
Chowdhury AA; Godbole NM; Chataut N; Kosanke S; Rodgers K; Awasthi S
Physiol Rep; 2022 Jul; 10(13):e15353. PubMed ID: 35838161
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 2 represses nonpilus adhesin-induced signaling in acute infections with the Pseudomonas aeruginosa pilA mutant.
Lorenz E; Chemotti DC; Vandal K; Tessier PA
Infect Immun; 2004 Aug; 72(8):4561-9. PubMed ID: 15271916
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 2 deficiency increases resistance to Pseudomonas aeruginosa pneumonia in the setting of sepsis-induced immune dysfunction.
Pène F; Grimaldi D; Zuber B; Sauneuf B; Rousseau C; El Hachem C; Martin C; Belaïdouni N; Balloy V; Mira JP; Chiche JD
J Infect Dis; 2012 Sep; 206(6):932-42. PubMed ID: 22782952
[TBL] [Abstract][Full Text] [Related]
15. Toll-Like Receptor 4 Agonistic Antibody Promotes Host Defense against Chronic Pseudomonas aeruginosa Lung Infection in Mice.
Nakamura S; Iwanaga N; Seki M; Fukudome K; Oshima K; Miyazaki T; Izumikawa K; Yanagihara K; Miyazaki Y; Mukae H; Kohno S
Infect Immun; 2016 Jul; 84(7):1986-1993. PubMed ID: 27091927
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary inflammation induced by bacteria-free outer membrane vesicles from Pseudomonas aeruginosa.
Park KS; Lee J; Jang SC; Kim SR; Jang MH; Lötvall J; Kim YK; Gho YS
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):637-45. PubMed ID: 23713467
[TBL] [Abstract][Full Text] [Related]
17. Intrapulmonary TNF gene therapy reverses sepsis-induced suppression of lung antibacterial host defense.
Chen GH; Reddy RC; Newstead MW; Tateda K; Kyasapura BL; Standiford TJ
J Immunol; 2000 Dec; 165(11):6496-503. PubMed ID: 11086090
[TBL] [Abstract][Full Text] [Related]
18. Chitinase 3-Like 1 (Chil1) Regulates Survival and Macrophage-Mediated Interleukin-1β and Tumor Necrosis Factor Alpha during Pseudomonas aeruginosa Pneumonia.
Marion CR; Wang J; Sharma L; Losier A; Lui W; Andrews N; Elias JA; Kazmierczak BI; Roy CR; Dela Cruz CS
Infect Immun; 2016 Jul; 84(7):2094-2104. PubMed ID: 27141083
[TBL] [Abstract][Full Text] [Related]
19. Killing of Pseudomonas aeruginosa by Chicken Cathelicidin-2 Is Immunogenically Silent, Preventing Lung Inflammation
Coorens M; Banaschewski BJH; Baer BJ; Yamashita C; van Dijk A; Haagsman HP; Veldhuizen RAW; Veldhuizen EJA
Infect Immun; 2017 Dec; 85(12):. PubMed ID: 28947647
[TBL] [Abstract][Full Text] [Related]
20. Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection.
LeVine AM; Kurak KE; Bruno MD; Stark JM; Whitsett JA; Korfhagen TR
Am J Respir Cell Mol Biol; 1998 Oct; 19(4):700-8. PubMed ID: 9761768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
